10-Q: Turning Point Brands Q3 Profit Soars on Stokers Growth

Turning Point Brands, Inc. reported a significant increase in net income and sales for the third quarter and first nine months of 2025, driven by strong performance in its Stokers products segment.

Summary

• Consolidated net sales for the three months ended September 30, 2025, increased by 31.2% to $118.98 million, up from $90.70 million in the prior year period.
• Net income attributable to Turning Point Brands, Inc. for the third quarter rose by 68.1% to $21.08 million, compared to $12.38 million in Q3 2024.
• Diluted earnings per share for the quarter increased to $1.13 from $0.68 in the prior year.
• The Stokers products segment saw an 80.8% increase in net sales to $74.83 million, primarily due to $31.6 million growth in modern oral products and $1.4 million in Stokers MST.
• The Zig-Zag products segment experienced a 10.5% decrease in net sales to $44.15 million, mainly due to declines in U.S. papers and wraps and the Clipper lighter business, partially offset by Canadian product growth.
• For the nine months ended September 30, 2025, consolidated net sales grew 28.1% to $342.05 million, and net income attributable to Turning Point Brands, Inc. increased 32.9% to $49.96 million.
• The company completed the divestiture of its Creative Distribution Solutions (CDS) segment on January 2, 2025, contributing it to General Wireless Operations, Inc. (GWO) in exchange for a 49% equity interest.
• Issued $300 million of 7.625% Senior Secured Notes due 2032 in February 2025, using proceeds to redeem the $250 million 5.625% Senior Secured Notes due 2026.
• Received a $5.5 million employee retention credit refund in the third quarter of 2025.
• Increased the share repurchase authorization by $100 million to an aggregate of $200 million on November 4, 2025, with $100 million remaining authority as of September 30, 2025.
• Sold 1,014,262 shares of common stock under an At-the-Market (ATM) program between August 15 and September 11, 2025, generating $97.5 million in net proceeds.

Sentiment

Score: 8

Explanation: The company demonstrated strong financial performance with significant increases in net sales and net income, driven by the high-growth Stokers segment. Cash position improved substantially, and debt was successfully refinanced. While the Zig-Zag segment declined and internal control remediation is ongoing, the overall financial health and strategic moves are positive.

Positives

• Consolidated net sales increased by 31.2% for the three months and 28.1% for the nine months ended September 30, 2025, demonstrating strong top-line growth.
• Net income attributable to Turning Point Brands, Inc. surged by 68.1% for the quarter and 32.9% for the nine months, indicating improved profitability.
• Stokers products segment net sales grew significantly by 80.8% for the quarter and 69.0% for the nine months, driven by modern oral products and MST.
• Gross profit margin improved to 59.2% for the quarter (from 55.6%) and 57.5% for the nine months (from 55.9%), primarily due to better margin contribution from modern oral products.
• Cash balance increased substantially to $201.19 million as of September 30, 2025, from $46.16 million at December 31, 2024.
• Successful refinancing of debt with the issuance of $300 million 2032 Notes, providing capital for general corporate purposes and debt repayment.
• Received a $5.5 million employee retention credit refund, contributing to other income.
• Increased share repurchase authorization by $100 million to $200 million, signaling confidence in future cash flow and commitment to shareholder returns.
• Successfully raised $97.5 million in net proceeds through the At-the-Market (ATM) offering program.

Negatives

• Zig-Zag products segment net sales decreased by 10.5% for the quarter and 5.5% for the nine months, primarily due to declines in U.S. papers and wraps and the Clipper lighter business.
• Selling, general, and administrative expenses increased significantly by 50.5% for the quarter and 38.0% for the nine months, outpacing revenue growth.
• Operating income as a percentage of net sales decreased to 21.8% for the quarter (from 22.9%) and 22.0% for the nine months (from 23.6%), mainly due to higher SG&A costs.
• Net cash provided by operating activities decreased by $12.4 million for the nine months ended September 30, 2025, compared to the prior year, primarily due to unfavorable changes in working capital.
• Net cash used in investing activities increased by $19.3 million for the nine months, driven by the purchase of an option for the Canadian distribution business and higher capital expenditures.
• Incurred a $0.9 million impairment charge related to the investment in Old Pal Holding Company, LLC during the nine months ended September 30, 2025.
• Incurred a $1.2 million loss on extinguishment of debt related to the redemption of the 2026 Notes.

Risks

• Declining sales of tobacco products and expected continuing decline in the tobacco industry overall.
• Dependence on a small number of third-party suppliers and producers, with potential for supply or product disruptions.
• Possibility of licenses to use certain brands or trademarks being terminated, challenged, or restricted.
• Failure to maintain consumer brand recognition and loyalty, and inability to anticipate and respond to changes in consumer preferences.
• Reliance on relationships with several large retailers and national chains for product distribution.
• Intense competition and ability to compete effectively, including from illicit sources.
• Substantial and increasing regulation and changes in U.S. Food and Drug Administration (FDA) enforcement priorities, including potential marketing denials or targeted flavor bans.
• Many products contain nicotine, considered a highly addictive substance.
• Requirement to maintain compliance with Master Settlement Agreement escrow account.
• Possible significant increases in federal, state, and local municipal tobaccoand nicotine-related taxes.
• Sensitivity of end-customers to increased sales taxes and adverse economic conditions, including inflation and declines in purchasing power.
• Complications with the design or implementation of the new enterprise resource planning system could adversely impact business and operations.
• Identification of material weaknesses in internal control over financial reporting, which, if not remediated, could result in loss of investor confidence and adversely impact stock price.

Future Outlook

The company expects to have ample liquidity to satisfy operating cash requirements for the foreseeable future, supported by its strong cash balance, free cash flow generation, and borrowing availability under the 2023 ABL Facility. Management anticipates completing the remediation of the identified material weakness in internal controls over financial reporting by the end of fiscal year 2025.

Management Comments

• Management views business performance through segments that closely resemble the performance of major product lines.
• Management believes it is most appropriate to assess the performance of the company's business without regard to FDA PMTA costs, and that adjusting for these costs provides investors and the public markets with the most meaningful metrics to assess performance of the business.
• Management has been implementing and continues to implement measures designed to ensure that control deficiencies contributing to the material weakness are remediated, such that these controls are designed, implemented, and operating effectively.
• Management believes the inventory loss from the December 2023 tornado damage is probable of being fully recovered under the company's stock throughput insurance policy.

Industry Context

The company operates in the alternative smoking accessories and Other Tobacco Products (OTP) industries. The alternative smoking accessories market is experiencing robust secular growth driven by cannabinoid legalization in the U.S. and Canada, and evolving consumer perception. The OTP industry, however, exhibited low-single-digit consumer unit annualized declines during 2024. The company's strong growth in modern oral products within its Stokers segment aligns with evolving consumer preferences and potentially mitigates some of the broader declines in traditional tobacco products.

Comparison to Industry Standards

• The OTP industry, which consists of non-cigarette tobacco products, exhibited low-single-digit consumer unit annualized declines during the year ended December 31, 2024, as reported by Management Science Associates, Inc. (MSAi). In contrast, the company's Stokers products segment, which includes modern oral products, achieved an 80.8% increase in net sales for Q3 2025, significantly outperforming the broader OTP market trend.
• The alternative smoking accessories market is experiencing robust secular growth driven by cannabinoid legalization in the U.S. and Canada. While the Zig-Zag segment, which includes rolling papers and related products, saw a decline, the company's strategic investments in Canadian distribution (Turning Point Brands Canada) aim to capitalize on this evolving market.

Corporate Governance

Legal Proceedings

• The company is subject to significant product liability litigation, particularly in the tobacco industry, with potential for substantial punitive and compensatory damages. The potential losses are not currently reasonably estimable and therefore not accrued.

Related Party Transactions

• On January 2, 2025, the company contributed its Creative Distribution Solutions (CDS) segment to General Wireless Operations, Inc. (GWO), a joint venture between the company and Standard General, LP, in exchange for a 49% equity interest in GWO.
• The company holds a purchase option with a 15-year term to acquire the remaining 51% equity interest in GWO, with an initial exercise price of $22.0 million, decreasing over time based on tax sharing payments to Standard General, LP.
• In August 2025, the GWO purchase option held by the company was amended, delaying the exercise ability until August 2027.
• Turning Point Brands Canada (a consolidated VIE) purchased an option from SBB (now part of GWO) to acquire a Canadian distribution business for fair market value less the option price (approximately $20.0 million, with $8.0 million paid at closing and the remainder paid quarterly over 18 months beginning February 2026).
• The Canadian distribution business will pay management fees to Turning Point Brands Canada for services, up to approximately $7.0 million per annum for a three-year period.

Stakeholder Impact

• **Shareholders**: Positive impact from increased net income, EPS, and the expanded share repurchase program. Potential for future dilution from the ATM program, but also capital for growth. The ongoing material weakness in internal controls could negatively impact investor confidence if not fully remediated.
• **Employees**: Potential impact from corporate restructuring costs, including severance and early retirement, though specific numbers are not detailed for employees.
• **Customers**: Continued availability of Zig-Zag and Stokers products, with growth in modern oral products catering to evolving preferences. Potential impact from regulatory changes like flavor bans.
• **Creditors**: Debt refinancing with new 2032 Notes at a higher principal amount and interest rate, but fixed, providing stability. Compliance with debt covenants is crucial.
• **Suppliers**: Dependence on a small number of third-party suppliers and producers means disruptions could impact product availability.

Next Steps

• Complete the remediation of the material weakness in internal controls over financial reporting by the end of fiscal year 2025.
• Continue to monitor and evaluate the progress of internal control remediation, with regular updates to the Audit Committee and Board of Directors.
• Pursue opportunistic execution of the increased share repurchase program.
• Capitalize on the option to purchase the remaining 51% equity interest in GWO starting August 2027.
• Turning Point Brands Canada's option to acquire the Canadian distribution business becomes exercisable in March 2027.

Key Dates

Recommendation

The company demonstrated robust financial performance in Q3 2025, with significant growth in net sales and net income, primarily driven by the high-growth Stokers segment and its modern oral products. The successful debt refinancing, substantial increase in cash on hand, and expanded share repurchase authorization signal strong financial health and a commitment to shareholder value. While the decline in the Zig-Zag segment and the un-remediated internal control weakness are areas to monitor, the overall strategic direction, market positioning in evolving consumer preferences, and strong profitability metrics suggest a positive outlook for long-term investors. The ATM program provides flexibility for future growth initiatives.

Keywords

Tobacco Products, Stokers, Zig-Zag, Modern Oral Products, SEC Filing, Quarterly Report, Financial Results, Consumer Products, Nicotine, FDA Regulation, Debt Refinancing, Share Repurchase, ATM Program, Internal Controls